The ability of manufacturers to convey the efficacy and safety of a new biosimilar is crucial.
Justin Smerker, PharmD, MSPBA
Advertisement
Articles by Justin Smerker, PharmD, MSPBA
Satisfaction surveys improve understanding of the patient journey and define specialty pharmacy excellence.
The transition to value-based reimbursement is likely to shape the future of health care.
There is little room for error in the highly competitive specialty pharmacy landscape.
Advertisement
Latest Updated Articles
Four Reasons Why Specialty Pharmacies FailPublished: March 27th 2017 | Updated:
Challenges for Value-Based Contracting in Specialty PharmacyPublished: May 1st 2017 | Updated:
Impact of Patient Satisfaction on Specialty PharmacyPublished: May 22nd 2017 | Updated:
Challenges for Launching Biosimilar ProductsPublished: July 10th 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Recognizing Immunizing Pharmacists in the Community
2
FDA, HHS Move to Accelerate Biosimilar Approvals
3
Accelerated Approval of Cancer Drugs: Benefit or Burden?
4
Denosumab Biosimilars Conexxence and Bomyntra Receive Interchangeability Designation
5
